Double‐Blind , Randomized, Placebo‐Controlled Trial of DA ‐9701 in Parkinson's Disease: PASS ‐ GI Study-Reference-Cited by-同舟云学术

Double‐Blind , Randomized, Placebo‐Controlled Trial of DA ‐9701 in Parkinson's Disease: PASS ‐ GI Study

Published:2020-08-06 Issue:11 Volume:35 Page:1966-1976
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Choi Ji‐Hyun¹,Lee Jee‐Young¹^ORCID,Cho Jin Whan²,Koh Seong‐Beom³,Yang Young Soon⁴,Yoo Dalla⁵^ORCID,Shin Cheol‐Min⁶,Kim Hee Tae⁷

Affiliation:

1. Department of Neurology, Seoul Metropolitan Government‐Seoul National University Boramae Medical Center Seoul National University College of Medicine Seoul South Korea

2. Department of Neurology, Samsung Medical Center Sungkyunkwan University School of Medicine Seoul South Korea

3. Department of Neurology Korea University Guro Hospital Seoul South Korea

4. Department of Neurology National Neuroscience Institute Singapore Singapore

5. Department of Neurology Kyung Hee University Hospital Seoul South Korea

6. Division of Gastroenterology, Department of Internal Medicine Seoul National University Bundang Hospital Seongnam South Korea

7. Department of Neurology Hanyang University Medical Center Seoul South Korea

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28219

Reference58 articles.

1. Gastrointestinal dysfunction in Parkinson's disease

2. Characterization of gastrointestinal disorders in patients with parkinsonian syndromes

3. Enteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease

4. Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses

5. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Drugs Tested in Clinical Trials for Alzheimer´s and Parkinson´s Diseases Treatment: Current Approaches in Tracking New Drugs;Frontiers in Clinical Drug Research - CNS and Neurological Disorders;2024-03-10

2. Gastrointestinal Dysfunction in Parkinson’s Disease: Neuro-Gastroenterology Perspectives on a Multifaceted Problem;Journal of Movement Disorders;2023-05-31

3. Sex differences in gastrointestinal dysfunction among patients with Parkinson’s disease;Neurological Sciences;2023-03-01

4. Mosapride-Induced Movement Disorders;Journal of Movement Disorders;2022-09-30

5. Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approaches;Frontiers in Aging Neuroscience;2022-08-11